Not only is FDA interested in learning more about direct-to-consumer genetic tests — the deputy director of the device evaluation section wrote a letter to the Pathway Genomics CEO asking him to provide the FDA clearance or approval number for Genetic Health Report or explain why he thinks it doesn't need clearance — so is the US House of Representatives.